1[1]Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their role in tumor invasion and metastasis. Eur J Cancer 2000;36:1621-30. 被引量：1
2[2]Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002;99:157-66. 被引量：1
3[3]Yana I, Seiki M. MT-MMPs play pivotal roles in cancer dissemination. Clin Exp Metastasis 2002;19:209-15. 被引量：1
4[4]Lang R, Braun M, Sounni NE, et al. Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features. J Mol Biol 2004;336:213-25. 被引量：1
5[5]Jiang A, Pei D. Distinct roles of catalytic and pexin-like domains in membrane-type matrix metalloproteinase (MMP)-mediated proMMP-2 activation and collagenolysis. J Biol Chem 2003;278:38765-71. 被引量：1
6[6]Ueno H, Nakamura H, Inoue M, et al. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 1997;57:2055-60. 被引量：1
7[7]Nakamura H, Ueno H,Yamashita K, et al. Enhanced production and activation of progelatinase A mediated by membrane-type 1matrix metalloproteinase in human papillary thyroid carcinomas.Cancer Res 1999;59:467-73. 被引量：1
8[8]Kang T, Yi J, Yang WR, et al. Functional characterization of MT3-MMP in transfected MDCK cells: progelatinase A activation and tubulogenesis in 3-D collagen lattice. FASEB J 2000;14:2559-68. 被引量：1
9[9]Kitagawa Y, Kunimi K, Uchibayashi T, etal. Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas. J Urol 1999;162:905-9. 被引量：1
10[10]Nuttall RK, Pennington CJ, Taplin J, et al. Elevated membranetype matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res2003;1:333-45. 被引量：1
